Trials / Completed
CompletedNCT02458768
Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.
A Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of s.c. Administration of IVF-M HP Inj. Versus Menopur® Inj. in Infertility Women Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies (ART) Such as in Vitro Fertilization-embryo Transfer (IVF-ET)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- Female
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to demonstrate the non-inferiority of IVFM HP Inj. by evaluating its efficacy versus Menopur® Inj. in infertility women undergoing the in vitro fertilization and embryo transfer (IVF-ET) among the assisted reproductive technologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IVF-M HP Inj. | |
| DRUG | Menopur® Inj. |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-11-01
- First posted
- 2015-06-01
- Last updated
- 2016-02-03
- Results posted
- 2016-02-03
Source: ClinicalTrials.gov record NCT02458768. Inclusion in this directory is not an endorsement.